These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Further observations on the use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome. Anders TF; Cann HM; Ciaranello RD; Barchas JD; Berger PA Neuropadiatrie; 1978 May; 9(2):157-66. PubMed ID: 308621 [TBL] [Abstract][Full Text] [Related]
3. The effect of L-5-hydroxytryptophan on self-mutilatin in Lesch-Nyhan disease: a negative report. Anderson LT; Herrmann L; Dancis J Neuropadiatrie; 1976 Nov; 7(4):439-42. PubMed ID: 1087383 [TBL] [Abstract][Full Text] [Related]
4. The Lesch-Nyhan syndrome. Nyhan WL Dev Med Child Neurol; 1978 Jun; 20(3):376-80. PubMed ID: 307504 [No Abstract] [Full Text] [Related]
5. Rare variant of Lesch-Nyhan syndrome without self-mutilation or nephrolithiasis. Kersnik Levart T Pediatr Nephrol; 2007 Nov; 22(11):1975-8. PubMed ID: 17680274 [TBL] [Abstract][Full Text] [Related]
8. A preventive approach to oral self-mutilation in Lesch-Nyhan syndrome: a case report. Jeong TS; Lee JH; Kim S; Kim JH; Tootla RG Pediatr Dent; 2006; 28(4):341-4. PubMed ID: 16903443 [TBL] [Abstract][Full Text] [Related]
9. Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters. Jankovic J; Caskey TC; Stout JT; Butler IJ Ann Neurol; 1988 May; 23(5):466-9. PubMed ID: 2455472 [TBL] [Abstract][Full Text] [Related]
10. Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome. Castells S; Chakrabarti C; Winsberg BG; Hurwic M; Perel JM; Nyhan WL J Autism Dev Disord; 1979 Mar; 9(1):95-103. PubMed ID: 312282 [TBL] [Abstract][Full Text] [Related]
11. Double-blind clinical trial of 5-hydroxytryptophan in a case of Lesch-Nyhan syndrome. Frith CD; Johnston EC; Joseph MH; Powell RJ; Watts RW J Neurol Neurosurg Psychiatry; 1976 Jul; 39(7):656-62. PubMed ID: 792398 [TBL] [Abstract][Full Text] [Related]
12. A review of behavioral treatments used for Lesch-Nyhan syndrome. Olson L; Houlihan D Behav Modif; 2000 Apr; 24(2):202-22. PubMed ID: 10804680 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin as a novel treatment for self-mutilation in Lesch-Nyhan syndrome. Dabrowski E; Smathers SA; Ralstrom CS; Nigro MA; Leleszi JP Dev Med Child Neurol; 2005 Sep; 47(9):636-9. PubMed ID: 16138673 [TBL] [Abstract][Full Text] [Related]
15. Oral self-mutilation in the Lesch-Nyhan syndrome. Lee JH; Berkowitz RJ; Choi BJ ASDC J Dent Child; 2002; 69(1):66-9, 12. PubMed ID: 12119817 [TBL] [Abstract][Full Text] [Related]
16. Lesch-Nyhan syndrome: successful prevention of lower lip ulceration caused by self-mutilation by use of mouth guard. Sugahara T; Mishima K; Mori Y Int J Oral Maxillofac Surg; 1994 Feb; 23(1):37-8. PubMed ID: 8163858 [TBL] [Abstract][Full Text] [Related]
17. Lesch-Nyhan disease: clinical experience with nineteen patients. Christie R; Bay C; Kaufman IA; Bakay B; Borden M; Nyhan WL Dev Med Child Neurol; 1982 Jun; 24(3):293-306. PubMed ID: 7095300 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin: treatment of self-mutilation in patients with Lesch-Nyhan syndrome. Gutierrez C; Pellene A; Micheli F Clin Neuropharmacol; 2008; 31(3):180-3. PubMed ID: 18520986 [TBL] [Abstract][Full Text] [Related]
19. A model of behavioral treatments for self-mutilation behavior in Lesch-Nyhan syndrome. Zilli EA; Hasselmo ME Neuroreport; 2008 Mar; 19(4):459-62. PubMed ID: 18287946 [TBL] [Abstract][Full Text] [Related]